Shares of drugmaker Sarepta (SRPT) are higher Tuesday on the back of an upgrade from RBC, but Jim Cramer says he's not adding shares to his portfolio. Cramer says that while it's possible that the company could get a takeover offer, he believes the easy money has been made. "I don't like to come in on top of the easy money being made," says Cramer. Sarepta shares have more than doubled over the past month, following a challenging start to 2016.
More from Video
How quickly do we find support, is what we'll want to know now, as the correction is occurring while economic optimism builds.
Despite the president's promise of no stimulus until after Nov. 3, there are no signs yet that this is the sort of correlated selling that leads to a deep correction.
Salesforce, Amgen and Honeywell will give a lift to the DJIA going forward.
CAG has hung onto the bulk of its recent gains, and could rise to the $50 area, according to the charts and indicators.